GATA2 and hereditary elliptocytosis: Exploring the precise molecular mechanisms guiding HE and blood specification upstream and downstream of GATA2 will help to facilitate new technologies for scalable blood cell production from hPSCs or through direct cellular reprogramming of somatic cells for use in transfusion and immunotherapies.